Ovarian Cancer Research Fund Alliance (OCRFA) is the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. As the voice for ovarian cancer, OCRFA funds private research, advocates for increased federal research and awareness dollars and furthers policies that give women access to the services they need, as well as supports women and their families before, during and after a diagnosis. OCRFA engages the survivor community with programs like Woman to Woman, pairing gynecologic cancer patients with gynecologic cancer survivors and Survivors Teaching Students®: Saving Women’s Lives, an educational program connecting ovarian cancer survivors with health professional students to present their unique stories and facts about the disease.
Ovarian Cancer Research Fund Alliance Blog
Oct 15, 2018
(October 15, 2018) This month in Nature, researchers from Weill Cornell published a study that helps to explain why the body’s natural immune response struggles to fight back against ovarian cancer. Using ovarian tumors from humans and mice, they found[…]Read more...
Oct 11, 2018
(October 11, 2018) The BMJ recently published a study from Denmark about the effect that newer birth control pills have on ovarian cancer risk. Researchers focused on two kinds of pills, those which contained both estrogen and progestogen or those[…]Read more...
Oct 9, 2018
(October 9, 2018) A study, published in JAMA Oncology, followed about 200,000 women over the course of 25 years in order to track their use of analgesics. A little over one-thousand of those women developed epithelial ovarian cancer within that[…]Read more...
Oct 2, 2018
(October 2, 2018) A study by the Mayo Clinic earlier this year aimed to increase the amount of genetic counseling referrals to epithelial ovarian cancer patients by supplying patients with a Genetics Referral Toolkit. The research was funded by OCRA[…]Read more...